Affordable Access

Uniocular miotic therapy.

Authors
  • Levene, R Z
Type
Published Article
Journal
Transactions. Section on Ophthalmology. American Academy of Ophthalmology and Otolaryngology
Publication Date
Jan 01, 1975
Volume
79
Issue
2
Identifiers
PMID: 1145961
Source
Medline
License
Unknown

Abstract

The beneficial and harmful effects of 2% pilocarpine and 0.125% echothiophate iodide were evaluated on the prospective study of uniocular miotic therapy using the fellow eye as a control. Thirty primary open-angle glaucoma patients were treated with pilocarpine alone over a median time of 55 months. Twenty-nine similar patients were treated initially with echothiophate iodide and subsequently with pilocarpine over a median time of 54 months. Pilocarpine is cataractogenic but the changes are less marked and require more time than those induced by echothiophate iodide. In the combined group of 118 eves of 59 patients there were 11 optic disc changes and dix glaucomatous field defects. There was no difference in incidence between the treated and control eyes. The results suggest that one should be conservative in prescribing miotics, including pilocarpine alone, for patients suspected of having glaucoma.

Report this publication

Statistics

Seen <100 times